CVGD CresAlta Global Dividend ETF
ETF on NYSE (US) · Actively managed · Listing
Changes appear once two quarterly filings are on file.
Largest holding: MSILF Government Portfolio, 10.6M units ($10.6M).
| Current positions Top 10 | % of book |
|---|---|
| MSILF Government Portfolio MVRXX $10.6M | 7.6% |
| CVS Health Corporation CVS $5.73M | 4.1% |
| Verizon Communications Inc. VZ $5.29M | 3.8% |
| Elevance Health, Inc. ELV $4.93M | 3.6% |
| Huntington Bancshares Incorporated HBAN $4.51M | 3.3% |
| Gilead Sciences, Inc. GILD $4.36M | 3.2% |
| Imperial Brands PLC IMBBY $4.08M | 2.9% |
| Salesforce, Inc. CRM $4.03M | 2.9% |
| Diageo plc DEO $3.67M | 2.7% |
| KDDI Corp KDDIY $3.53M | 2.5% |
Slices are % of holdings value.
| Sectors | % of holdings value |
|---|---|
| Healthcare | 18.0% |
| Financial Services | 12.9% |
| Technology | 10.1% |
| Communication Services | 8.3% |
| Consumer Defensive | 7.2% |
| Basic Materials | 5.7% |
| Energy | 3.6% |
| Industrials | 2.5% |
| Other (2) | 2.6% |
| Unclassified | 29.1% |
| Industries | % of holdings value |
|---|---|
| Software - Application | 10.1% |
| Healthcare Plans | 7.7% |
| Specialty Chemicals | 5.7% |
| Internet Content & Information | 4.5% |
| Telecom Services | 3.8% |
| Drug Manufacturers - General | 3.8% |
| Medical Devices | 3.4% |
| Other (16) | 32.0% |
| Unclassified | 29.1% |
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jul 31, 2026 (Form N-PORT). Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Apr 30, 2026.
The investment objective of CresAlta Global Dividend ETF (the "Fund") is long-term capital appreciation and income generation.
Principal investment strategies
The Fund is an actively managed exchange-traded fund ("ETF") that invests, under normal circumstances, at least 80% of its assets in dividend paying equity securities at the time of purchase. The Adviser seeks to achieve for the Fund's objective by investing in U.S. and non-U.S. companies that the Adviser believes are financially strong and well-managed. The Adviser begins by reviewing a universe of more than 3,500 companies using proprietary screening methods to identify companies that the Adviser believes have low valuations and the potential to pay dividends from strong recurring cash flows or have the capacity to pay high dividends in the future. The Adviser selects 35-50 companies across market sectors and avoids concentrating in any one company or industry. The Adviser's stock selection process combines macroeconomic analysis, quantitative stock ranking, and traditional company fundamental analysis. The process is not an automated model. Buying and selling decisions are at the portfolio manager's discretion based on review of the research. 1. The Adviser's macroeconomic analysis divides business cycles into four phases— trough, early recovery, expansion, and peak—using a combination of factors, such as Purchasing Managers Index data (PMI) and inflation, to estimate the current phase and direction of the business cycle. This macro business phase analysis informs the quantitative stock ranking and traditional fundamental analysis by helping to determine which segment of the stock market will benefit most from the current phase and direction of the business cycle. 2. The quantitative stock ranking is based on an analysis of factors in three distinct "factor families": price momentum, valuation, and business fundamentals. Stocks are ranked based on a combination of factor families that is appropriate for the current phase and direction of the business cycle. 3. The Adviser's traditional company analysis includes an assessment of financial statements and financial history; corporate strategy and business outlook; competitive landscape; macroeconomic backdrop; and management effectiveness. The Adviser uses a value-investing framework centered around dividends to classify stocks via traditional fundamental analysis to build portfolios. The Adviser's classification system identifies stocks as dividend value, dividend growth, or dividend payor. Portfolios are often heavily allocated to dividend growth, which the Adviser defines as higher quality companies—usually with lower balance sheet leverage, strong free cash flows, clear capital allocation plans, defensible businesses, an ability to grow dividends and share buybacks at an above market pace. Dividend value and dividend payor stocks provide diversification during appropriate business cycle phases. At the company level, the Adviser considers company cash flow, balance sheet, and other financial metrics, and both positive and negative catalysts, including events such as changes in key leadership positions and cuts in the dividend, in making investment decisions for the Fund. The Adviser may also consider the impact of trading on tax efficiency in its investment decision making process. 2 Additionally, the Adviser utilizes a macroeconomic overlay to determine the business cycle phase of countries while rotating portfolio positions across stocks categorized with the Adviser's dividend category methodology. Stocks are categorized into one of three dividend categories — dividend value, dividend growth, and dividend payer. The bulk of the portfolio is expected to consist of dividend growth stocks. The Adviser seeks to obtain for the Fund substantial returns from such stocks via growing dividends and share buybacks. The portfolio may tilt toward dividend value or dividend payer stocks depending on the business cycle phase. Under normal circumstances, the Fund expects to invest at least 40% of its total assets in equity securities of non-U.S.
Management and Contact
- Adviser
- CresAlta Investment Management, Inc.
- Sub-adviser
- Vident Asset Management
- Portfolio managers
-
Joshua Stevens, Chief Investment Officer of CresAlta and Sr. VP of Investments at AMG National Trust Bank, has served the Fund as portfolio manager ("Portfolio Manager") since it commenced operations in 2026.
- Phone
- 1.855.704.4684
- Website
- cresalta.com
Holdings as of Jul 31, 2026
The full portfolio as of the quarter end Jul 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Sep 28, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative.
44 lines, 34 linked, weights sum to 99.87% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Weight | Market value |
|---|---|---|---|---|---|
|
MSILF Government Portfolio
|
MVRXX US61747C7074 | Money market | 10,563,964.95 | 7.62% | $ 10.564M |
| CVS Health Corp | CVS US1266501006 | Equity | 54,893 | 4.14% | $ 5.732M |
| Verizon Communications Inc | VZ US92343V1044 | Equity | 112,927 | 3.81% | $ 5.286M |
| Elevance Health Inc | ELV US0367521038 | Equity | 13,113 | 3.56% | $ 4.928M |
| Huntington Bancshares Inc/OH | HBAN US4461501045 | Equity | 264,515 | 3.25% | $ 4.507M |
| Gilead Sciences Inc | GILD US3755581036 | Equity | 33,499 | 3.15% | $ 4.362M |
|
Imperial Brands PLC
|
IMBBY US45262P1021 | Equity | 107,976 | 2.95% | $ 4.083M |
| Salesforce Inc | CRM US79466L3024 | Equity | 21,913 | 2.91% | $ 4.032M |
| Diageo PLC | DEO US25243Q2057 | Equity | 41,689 | 2.65% | $ 3.671M |
|
KDDI Corp
|
KDDIY US48667L1061 | Equity | 192,817 | 2.54% | $ 3.527M |
| Dollar General Corp | DG US2566771059 | Equity | 27,562 | 2.53% | $ 3.502M |
| Charles Schwab Corp/The | SCHW US8085131055 | Equity | 32,635 | 2.48% | $ 3.435M |
| Willis Towers Watson PLC | WTW IE00BDB6Q211 | Equity | 10,178 | 2.47% | $ 3.419M |
|
Brenntag SE
|
BNTGY US1071801013 | Equity | 238,959 | 2.43% | $ 3.367M |
|
Heineken NV
|
HEINY US4230123014 | Equity | 72,679 | 2.40% | $ 3.32M |
| RELX PLC | RELX US7595301083 | Equity | 93,389 | 2.39% | $ 3.308M |
| Microsoft Corp | MSFT US5949181045 | Equity | 7,012 | 2.35% | $ 3.259M |
|
BNP Paribas SA
|
BNPQY US05565A2024 | Equity | 50,200 | 2.29% | $ 3.174M |
| Koninklijke Philips NV | PHG US5004723038 | Equity | 116,027 | 2.20% | $ 3.052M |
|
Daikin Industries Ltd
|
DKILY US23381B1061 | Equity | 201,371 | 2.11% | $ 2.919M |
| PPG Industries Inc | PPG US6935061076 | Equity | 26,363 | 2.10% | $ 2.914M |
| Alibaba Group Holding Ltd | BABA US01609W1027 | Equity | 23,608 | 2.08% | $ 2.886M |
| SAP SE | SAP US8030542042 | Equity | 15,240 | 2.02% | $ 2.798M |
| J M Smucker Co/The | SJM US8326964058 | Equity | 23,456 | 2.02% | $ 2.797M |
| SLB Ltd | SLB AN8068571086 | Equity | 54,664 | 1.96% | $ 2.711M |
|
adidas AG
|
ADDYY US00687A1079 | Equity | 28,819 | 1.92% | $ 2.662M |
| Sanofi SA | SNY US80105N1054 | Equity | 61,723 | 1.92% | $ 2.659M |
|
Bayer AG
|
BAYRY US0727303028 | Equity | 188,824 | 1.89% | $ 2.623M |
| Dow Inc | DOW US2605571031 | Equity | 85,831 | 1.88% | $ 2.6M |
| Novo Nordisk A/S | NVO US6701002056 | Equity | 54,442 | 1.85% | $ 2.563M |
| Citigroup Inc | C US1729674242 | Equity | 18,108 | 1.73% | $ 2.398M |
| Celanese Corp | CE US1508701034 | Equity | 53,552 | 1.73% | $ 2.395M |
| Intuit Inc | INTU US4612021034 | Equity | 7,383 | 1.68% | $ 2.334M |
| EOG Resources Inc | EOG US26875P1012 | Equity | 15,562 | 1.67% | $ 2.314M |
| Marsh & McLennan Cos Inc | MRSH US5717481023 | Equity | 12,045 | 1.65% | $ 2.285M |
|
Akzo Nobel NV
|
AKZOY US0101995035 | Equity | 92,659 | 1.56% | $ 2.161M |
| National Grid PLC | NGG US6362744095 | Equity | 26,548 | 1.53% | $ 2.123M |
| Warner Bros Discovery Inc | WBD US9344231041 | Equity | 72,424 | 1.37% | $ 1.905M |
| Prudential PLC | PUK US74435K2042 | Equity | 60,099 | 1.31% | $ 1.819M |
| Sunbelt Rentals Holdings Inc | SUNB US8669661048 | Equity | 24,218 | 1.26% | $ 1.742M |
| CSX Corp | CSX US1264081035 | Equity | 33,798 | 1.23% | $ 1.703M |
| Baxter International Inc | BAX US0718131099 | Equity | 61,914 | 1.17% | $ 1.62M |
| Paychex Inc | PAYX US7043261079 | Equity | 12,919 | 1.09% | $ 1.509M |
| Lennar Corp | LEN US5260571048 | Equity | 17,603 | 1.05% | $ 1.45M |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up